L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3141
ETF rank
โ‚น2.09 B
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
โ‚น1,419
Share price
-0.35%
Change (1 day)
49.43%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of July 2026: 0.49%